Use access key #2 to skip to page content.
  • S&P 500: 896.42
  • Change: -2.91%
$12.42 -0.38 (-2.97%)
7/2/2009 4:00 PM

Mylan Laboratories, Inc. (MYL)

CAPS Rating:
*****

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating MYL

Add Stock to Watchlist

What the Community Thinks

Total Members

493 Outperforms
28 Underperforms
 

All-Stars

177 Outperforms
4 Underperforms
 

Wall Street

16 Outperforms
1 Underperforms
 

Members bullish on MYL are also bullish on:

Members bearish on MYL are also bearish on:

Ticker Tags

Healthcare (770), Pharmaceuticals (157), Mid Cap (488), S&P 500 (452)
Suggest a tag

Mylan Laboratories, Inc. At A Glance

Current Price: $12.42
Last Trade Time: 7/2/2009 4:00 PM
Open: $0.00
Previous Close: $12.80
Daily Range: $12.30 - $12.85
52-Week Range: $5.75 - $14.94
Volume: 00
Market Cap: $3.90B
P/E Ratio: 19.69
Compare Our Special Broker Offers!

Stock Trends

MYL VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

3

Mylan Laboratories, Inc. (MYL)

Avatar RXDOC73 (99.39) Submitted: 10/28/08 3:44 PM

The population is just getting older and more people are going to need more drugs. There is a great deal of consolidation in the field and only the strong companies like this one will survive the fallout.

Also a great takeover target for the likes of TEVA.

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

3

Mylan Laboratories, Inc. (MYL)

Avatar DouglasRich (< 20) Submitted: 1/29/08 9:30 AM

Mylan is known for making good quality, reliable generic pharmaceutical products, but I think their primary drawback is they haven't found a way to outcompete the generic market. In the pharmacy, cheaper generics are preferred to Mylan's oftentimes more expensive products. Teva and Dr. Reddy are t...More

Replies: 1 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 88 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (MYL)

Avatar darksabre (28.24) Submitted: 5/12/09 12:35 PM : Outperform Start Price: $13.78 MYL Score: -9.04

Generics

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (MYL)

Avatar stockfreak1 (27.42) Submitted: 4/23/09 2:31 PM : Outperform Start Price: $14.12 MYL Score: -18.00

Long - Generic advancement.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (MYL)

Avatar gea1968 (95.01) Submitted: 4/18/09 7:19 PM : Outperform Start Price: $14.50 MYL Score: -19.34

fundamentals and momentum; favorable StockScouter rating

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (MYL)

Avatar MightyPeepAnt (90.98) Submitted: 4/16/09 8:44 AM : Outperform Start Price: $14.25 MYL Score: -17.36

New generics being produced of high need drugs.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (MYL)

Avatar stevez24 (77.14) Submitted: 3/26/09 12:25 PM : Outperform Start Price: $13.59 MYL Score: -18.01

obama health plan increases use of generics

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 88 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 17 of 17  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackRBCCapMkts 88.51 04/23/09 Outperform NS $14.49-14.29%+6.03%-20.32
TrackBarclaysCap 96.99 02/23/09 Outperform NS $12.99-4.39%+14.74%-19.13
TrackStanfordRes 83.71 09/25/08 Outperform NS $12.02+3.33%-24.85%+28.17
TrackNeedham 75.83 09/25/08 Outperform NS $12.02+3.33%-24.85%+28.17
TrackCarisandCo 83.79 06/13/08 Outperform NS $12.56-1.11%-33.23%+32.11
TrackScottBleier 94.06 06/13/08 Outperform 3M $12.59-1.35%-34.04%+32.69
TrackSoros 79.40 03/31/08 Outperform NS $11.60+7.07%-31.95%+39.02 Toggle the visibility of 60-Second Pitch and replies
TrackCitigroup 87.14 03/14/08 Outperform NS $11.17+11.19%-32.36%+43.55
TrackPatDorsey 76.15 01/04/08 Outperform 5Y $13.69-9.28%-36.44%+27.17
TrackBofASec 95.34 12/18/07 Outperform NS $13.80-10.00%-38.53%+28.53
TrackBernstein 82.50 11/15/07 Outperform NS $14.27-12.96%-38.73%+25.76
TrackJPMorgan 82.92 10/04/07 Outperform NS $17.21-27.83%-41.72%+13.89
TrackDreman 91.15 09/30/07 Outperform NS $15.96-22.18%-41.14%+18.96 Toggle the visibility of 60-Second Pitch and replies
TrackCreditSuiss 89.18 09/10/07 Outperform NS $15.59-20.33%-38.70%+18.37
TrackUBS 86.07 09/10/07 Outperform NS $15.59-20.33%-38.70%+18.37
TrackMatrix 88.79 11/20/06 Outperform NS $20.67-39.92%-35.96%-3.96
TrackJimCramer 64.82 08/09/06 Underperform 3W $19.75-37.11%-29.65%+7.46

Results 1 - 17 of 17  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD02 265ms